期刊
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
卷 320, 期 5, 页码 R697-R703出版社
AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpregu.00338.2020
关键词
amylin; antibody; CGRP; cross-reactivity; pancreas
类别
资金
- Marsden Fund (Royal Society of New Zealand)
- Royal Society of New Zealand
- Health Research Council (New Zealand)
- University of Auckland
This study found that current amylin antibodies frequently cross-react with CGRP, making them unsuitable for use in tissues that highly express CGRP. Therefore, previous studies using these antibodies should be reevaluated in light of these findings.
Amylin is a 37-amino acid endocrine hormone secreted from the pancreas in response to nutrient intake, acting centrally to promote meal-ending satiation. With many studies linking amylin action to the nervous system, determining the distribution or expression of amylin in the nervous system is critical. However, amylin shares sequence identity and structural homology to the related neuropeptide calcitonin gene-related peptide (CGRP). This creates challenges in identifying selective amylin antibodies that do not cross-react with CGRP, especially in neural tissues, where CGRP is densely packed into secretory vesicles. Here, we characterized eight amylin antibodies to determine their ability to detect amylin and cross-react with rat or human alpha CGRP, using immunoblots and preabsorption controls in rat pancreas. We observed that amylin antibodies frequently cross-reacted with alpha CGRP and are therefore not suitable for use in tissues that highly express CGRP. Earlier work using these antibodies should be revisited in light of our findings.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据